Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.50 |
| ▸ | CA6 | P23280 | 5/20 | 0.50 |
| ▸ | CA7 | P43166 | 5/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.47 |
| ▸ | CA5A | P35218 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254034 | 0.90 | — | — | |
| Ethylamine SCHEMBL2885890 | 0.89 | TSHR (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL30662357 | 0.87 | — | — | |
| SCHEMBL2785775 | 0.87 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6304048 | 0.87 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5366267 | 0.87 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6303811 | 0.87 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL16697581 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL3074798 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL14782411 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630669-B2 | Waterborne epoxy curing agent | EVONIK OPERATIONS GMBH (DE) | 2026-05-19 | — | — | US | claimed |
| US-20250066535-A1 | WATERBORNE EPOXY CURING AGENT | EVONIK OPERATIONS GMBH (DE) | 2025-02-27 | — | — | US | claimed |
| CN-115109230-A | Aqueous epoxy curing agent | 赢创运营有限公司 | 2022-09-27 | — | — | CN | claimed |
| US-20220298296-A1 | WATERBORNE EPOXY CURING AGENT | EVONIK OPERATIONS GMBH (DE) | 2022-09-22 | — | — | US | claimed |
| US-8063161-B2 | Low temperature curing acrylate and maleimide based formulations and methods for use thereof | DESIGNER MOLECULES, INC. (US) | 2011-11-22 | — | — | US | claimed |
| US-20100063184-A1 | LOW TEMPERATURE CURING ACRYLATE AND MALEIMIDE BASED FORMULATIONS AND METHODS FOR USE THEREOF | DESIGNER MOLECULES, INC. (US) | 2010-03-11 | — | — | US | claimed |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-05-21 | — | — | US | disclosed |
| US-12630669-B2 | Waterborne epoxy curing agent | EVONIK OPERATIONS GMBH (DE) | 2026-05-19 | — | — | US | disclosed |
| US-20250122418-A1 | Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds | CLARIANT INT LTD (CH) | 2025-04-17 | — | — | US | disclosed |
| US-20250066535-A1 | WATERBORNE EPOXY CURING AGENT | EVONIK OPERATIONS GMBH (DE) | 2025-02-27 | — | — | US | disclosed |
| US-12173113-B2 | Waterborne epoxy curing agent | EVONIK OPERATIONS GMBH (DE) | 2024-12-24 | — | — | US | disclosed |
| US-12129427-B2 | Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds | CLARIANT INTERNATIONAL LTD (CH) | 2024-10-29 | — | — | US | disclosed |
| US-11981876-B2 | Wax inhibitors with improved flowability | CLARIANT INTERNATIONAL LTD (CH) | 2024-05-14 | — | — | US | disclosed |
| EP-0939855-A1 | ADDITIVES FOR INHIBITING FORMATION OF GAS HYDRATES | Clariant GmbH (DE) | 1999-09-08 | — | — | EP | disclosed |
| EP-0848043-A2 | Pigment dispersant and pigment dispersion, especially suitable for color filters | DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) | 1998-06-17 | — | — | EP | disclosed |
| WO-1998023843-A1 | ADDITIVES FOR INHIBITING FORMATION OF GAS HYDRATES | CLARIANT GMBH (DE) | 1998-06-04 | — | — | WO | disclosed |
| US-5360564-A | Hydrogenated star polymers | SHELL OIL COMPANY (US) | 1994-11-01 | — | — | US | disclosed |
| CN-1008815-B | Process for synthesizing dipropylamine by hydrogenation of acrylonitrile | FUSHUN RESEARCH INST OF CHEM E (CN) | 1990-07-18 | — | — | CN | disclosed |
| US-4935511-A | Nervous system, gastrointestinal disorders | RORER PHARMACEUTICAL CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4313766-A | Process for the production of a pigment composition | CIBA-GEIGY CORPORATION (US) | 1982-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129427-B2 | Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, MTDH | CA12 1066/4885CA6 411/4885CA7 235/4885 |
| US-20250122418-A1 | Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, AQP1 | CA12 466/4885CA6 176/4885CA7 140/4885 |
| US-12630669-B2 | Waterborne epoxy curing agent | PNMT, EPHX2, EPHX1 | CA12 3619/4885CA6 3690/4885CA7 3524/4885 |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | MAT1A, MAT2B, MAT2A | CA12 4678/4885CA6 4468/4885CA7 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.